On-Eye Evaluation of Contact Lens Axis Location

NCT ID: NCT02100410

Last Updated: 2014-05-16

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-04-30

Study Completion Date

2013-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to evaluate the axis location of toric contact lenses after 3 minutes of wear. During this 1-visit study, each participant wore 3 pairs of study lenses of various design iterations (2-87-1, 2-87-2, 2-87-3) for an exposure time of approximately 30 minutes each. Each pair consisted of lenses of the same design iteration, 1 lens with embossed mark \[TEST1 (T1), TEST3 (T3), TEST5 (T5)\], worn on the right eye, and 1 lens without embossed mark \[TEST2 (T2), TEST4 (T4), and TEST6 (T6)\] worn on the left eye.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myopia Astigmatism Refractive Error

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Iteration 2-87-1

Delefilcon A toric contact lenses T1 and T2 worn contralaterally (1 in each eye) for approximately 30 minutes

Group Type EXPERIMENTAL

Delefilcon A toric contact lens T1

Intervention Type DEVICE

Iteration 2-87-1 with embossed mark

Delefilcon A toric contact lens T2

Intervention Type DEVICE

Iteration 2-87-1 without embossed mark

Iteration 2-87-2

Delefilcon A toric contact lenses T3 and T4 worn contralaterally (1 in each eye) for approximately 30 minutes

Group Type EXPERIMENTAL

Delefilcon A toric contact lens T3

Intervention Type DEVICE

Iteration 2-87-2 with embossed mark

Delefilcon A toric contact lens T4

Intervention Type DEVICE

Iteration 2-87-2 without embossed mark

Iteration 2-87-3

Delefilcon A toric contact lenses T5 and T6 worn contralaterally (1 in each eye) for approximately 30 minutes

Group Type EXPERIMENTAL

Delefilcon A toric contact lens T5

Intervention Type DEVICE

Iteration 2-87-3 with embossed mark

Delefilcon A toric contact lens T6

Intervention Type DEVICE

Iteration 2-87-3 without embossed mark

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Delefilcon A toric contact lens T1

Iteration 2-87-1 with embossed mark

Intervention Type DEVICE

Delefilcon A toric contact lens T2

Iteration 2-87-1 without embossed mark

Intervention Type DEVICE

Delefilcon A toric contact lens T3

Iteration 2-87-2 with embossed mark

Intervention Type DEVICE

Delefilcon A toric contact lens T4

Iteration 2-87-2 without embossed mark

Intervention Type DEVICE

Delefilcon A toric contact lens T5

Iteration 2-87-3 with embossed mark

Intervention Type DEVICE

Delefilcon A toric contact lens T6

Iteration 2-87-3 without embossed mark

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Sign written Informed Consent.
* Best corrected distance visual acuity greater than or equal to 20/25 in each eye.

Exclusion Criteria

* History of any ocular surgery or ocular injury within 12 weeks of enrollment for this study.
* Anterior segment disease, infection, inflammation, or abnormality that contraindicates contact lens wear.
* History of herpetic keratitis.
* Slit-lamp findings at baseline as specified in the protocol.
* Any use of systemic or ocular medications for which contact lens wear could be contraindicated, including ocular medications that require instillation during contact lens wear.
* Clinically significant dry eye not responding to treatment.
* History of refractive surgery.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alcon Research

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Joachim Nick, Dipl. Ing.

Role: STUDY_DIRECTOR

Alcon Research

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

C-12-061

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.